Page 123 - 南京医科大学自然版

第44卷第10期 端家豪，张 浥，杨 玲. T细胞亚群在射血分数保留的心力衰竭中的研究进展［J］.
2024年10月 南京医科大学学报（自然科学版），2024，44（10）：1435-1440 ·1439 ·

Transl Sci，2022，7（2）：116-127 to heart failure during chronic pressure overload［J］. Cir⁃
［5］ GUO Y Z，WEN J J，HE A，et al. iNOS contributes to culation，2014，129（21）：2111-2124
heart failure with preserved ejection fraction through mito⁃ ［18］BRASSINGTON K，KANELLAKIS P，CAO A，et al. Cross⁃
+
chondrial dysfunction and Akt S⁃nitrosylation［J］. J Adv talk between cytotoxic CD8 T cells and stressed cardio⁃
Res，2023，43：175-186 myocytes triggers development of interstitial cardiac fibro⁃
［6］ DAOU D，GILLETTE T G，HILL J A. Inflammatory mech⁃ sis in hypertensive mouse hearts［J］. Front Immunol，
anisms in heart failure with preserved ejection fraction［J］. 2022，13：1040233
Physiology，2023，38（5）：217-230 ［19］SMOLGOVSKY S，BAYER A L，KAUR K，et al. Impaired
［7］ BASHIR Z，CHEN E W，TORI K，et al. Insight into differ⁃ T cell IRE1α/XBP1 signaling directs inflammation in ex⁃
ent phenotypic presentations of heart failure with pre⁃ perimental heart failure with preserved ejection frac⁃
served ejection fraction［J］. Prog Cardiovasc Dis，2023， tion［J］. J Clin Invest，2023，133（24）：e171874
79：80-88 ［20］PARK C O，KUPPER T S. The emerging role of resident
［8］ SHI Y Y，LU Y C，YOU J. Unfolded protein response in memory T cells in protective immunity and inflammatory
+
the activation ⁃ induced biological processes of CD8 T disease［J］. Nat Med，2015，21（7）：688-697
cells［J］. Pharmacol Res，2021，169：105654 ［21］LIAO S G，TANG Y，YUE X，et al. β⁃hydroxybutyrate mit⁃
［9］ RUSH C J，BERRY C，OLDROYD K G，et al. Prevalence igated heart failure with preserved ejection fraction by in⁃
of coronary artery disease and coronary microvascular dys⁃ creasing Treg cells via Nox2/GSK⁃3β［J］. J Inflamm Res，
function in patients with heart failure with preserved ejec⁃ 2021，14：4697-4706
tion fraction［J］. JAMA Cardiol，2021，6（10）：1130-1143 ［22］OVCHINNIKOV A，FILATOVA A，POTEKHINA A，et al.
［10］SWIRSKI F K，NAHRENDORF M. Cardioimmunology： Blood immune cell alterations in patients with hyperten⁃
the immune system in cardiac homeostasis and disease［J］. sive left ventricular hypertrophy and heart failure with
Nat Rev Immunol，2018，18（12）：733-744 preserved ejection fraction［J］. J Cardiovasc Dev Dis，
［11］LOFFREDO F S，STEINHAUSER M L，JAY S M，et al. 2023，10（7）：310
Growth differentiation factor 11 is a circulating factor that ［23］YOSHITOMI H. Peripheral helper T cell responses in hu⁃
reverses age⁃related cardiac hypertrophy［J］. Cell，2013， man diseases［J］. Front Immunol，2022，13：946786
153（4）：828-839 ［24］LIANG X Y，BAI Z C，WANG F F，et al. Full⁃length tran⁃
［12］DEBERGE M，SHAH S J，WILSBACHER L，et al. Macro⁃ scriptome sequencing：an insight into the dog model of
phages in heart failure with reduced versus preserved heart failure［J］. Front Cardiovasc Med，2021，8：712797
ejection fraction［J］. Trends Mol Med，2019，25（4）：328- ［25］FUKUNAGA T，SOEJIMA H，IRIE A，et al. Relation be⁃
+
340 tween CD4 T⁃cell activation and severity of chronic heart
［13］PANICO C，FELICETTA A，KUNDERFRANCO P，et al. failure secondary to ischemic or idiopathic dilated cardio⁃
Single⁃cell RNA sequencing reveals metabolic stress⁃de⁃ myopathy［J］. Am J Cardiol，2007，100（3）：483-488
pendent activation of cardiac macrophages in a model of ［26］SAVA R I，PEPINE C J，MARCH K L. Immune dysregula⁃
dyslipidemia⁃induced diastolic dysfunction［J/OL］. Circu⁃ tion in HFpEF：a target for mesenchymal stem/stromal
lation，2023（2023⁃12⁃21）［2024⁃3⁃10］. DOI：10.1161/ cell therapy［J］. J Clin Med，2020，9（1）：241
CIRCULATIONAHA.122.062984 ［27］ANGELIS E D，PECORARO M，RUSCIANO M R，et al.
［14］LIU H，HUANG Y M，ZHAO Y，et al. Inflammatory mac⁃ Cross⁃talk between neurohormonal pathways and the im⁃
rophage interleukin ⁃ 1β mediates high ⁃ fat diet ⁃ induced mune system in heart failure：a review of the literature［J］.
heart failure with preserved ejection fraction［J］. JACC Int J Mol Sci，2019，20（7）：1698
Basic Transl Sci，2023，8（2）：174-185 ［28］SABAT R，GRÜTZ G，WARSZAWSKA K，et al. Biology
［15］BANSAL S S，ISMAHIL M A，GOEL M，et al. Dysfunc⁃ of interleukin⁃10［J］. Cytokine Growth Factor Rev，2010，
tional and proinflammatory regulatory T⁃lymphocytes are 21（5）：331-344
essential for adverse cardiac remodeling in ischemic car⁃ ［29］HU W L，LI J Y，CHENG X. Regulatory T cells and car⁃
diomyopathy［J］. Circulation，2019，139（2）：206-221 diovascular diseases［J］. Chin Med J，2023，136（23）：
［16］RAMOS G C，VAN DEN BERG A，NUNES⁃SILVA V，et 2812-2823
al. Myocardial aging as a T⁃cell⁃mediated phenomenon［J］. ［30］LU Y Z，XIA N，CHENG X. Regulatory T cells in chronic
Proc Natl Acad Sci U S A，2017，114（12）：E2420-E2429 heart failure［J］. Front Immunol，2021，12：732794
［17］LAROUMANIE F，DOUIN⁃ECHINARD V，POZZO J，et ［31］WEIRATHER J，HOFMANN U D，BEYERSDORF N，et
+
+
al. CD4 T cells promote the transition from hypertrophy al. Foxp3+ CD4 T cells improve healing after myocardial